Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 11Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Nasopharyngeal Carcinoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Neoplasms 2Adenocarcinoma 2Pathologic Complete Response 1Overall Survival Comparison Between the 2 Arms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Margins of Excision 1Lymphatic Metastasis 1Locally Advanced Malignant Neoplasm 1Laryngeal Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1HPV-Related Squamous Cell Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Adenosquamous 1Breast Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Gemcitabine 11Cisplatin 11Radiotherapy, Intensity-Modulated 6tislelizumab 2nimotuzumab 2camrelizumab 2Fluorouracil 2Carboplatin 2spartalizumab 1sintilimab 1sargramostim 1pembrolizumab 1fosaprepitant 1etoposide phosphate 1Tropisetron 1Radiotherapy 1Induction Chemotherapy 1Ifosfamide 1Etoposide 1Docetaxel 1Dexamethasone 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Nasopharyngeal Neoplasms × Chemoradiotherapy × Clear all
NCT01074021 2015-10-30

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 3 Unknown
480 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡